176 related articles for article (PubMed ID: 36569097)
41. FUS/TLS Suppresses Enterovirus Replication and Promotes Antiviral Innate Immune Responses.
Xue YC; Ng CS; Mohamud Y; Fung G; Liu H; Bahreyni A; Zhang J; Luo H
J Virol; 2021 May; 95(12):. PubMed ID: 33827951
[TBL] [Abstract][Full Text] [Related]
42. Human cardiac-derived adherent proliferating cells reduce murine acute Coxsackievirus B3-induced myocarditis.
Miteva K; Haag M; Peng J; Savvatis K; Becher PM; Seifert M; Warstat K; Westermann D; Ringe J; Sittinger M; Schultheiss HP; Tschöpe C; Van Linthout S
PLoS One; 2011; 6(12):e28513. PubMed ID: 22174827
[TBL] [Abstract][Full Text] [Related]
43. Dual roles of calpain in facilitating Coxsackievirus B3 replication and prompting inflammation in acute myocarditis.
Li M; Su Y; Yu Y; Yu Y; Wang X; Zou Y; Ge J; Chen R
Int J Cardiol; 2016 Oct; 221():1123-31. PubMed ID: 27472894
[TBL] [Abstract][Full Text] [Related]
44. Activation of CaMKII via ER-stress mediates coxsackievirus B3-induced cardiomyocyte apoptosis.
Nie J; Ta N; Liu L; Shi G; Kang T; Zheng Z
Cell Biol Int; 2020 Feb; 44(2):488-498. PubMed ID: 31631456
[TBL] [Abstract][Full Text] [Related]
45. Cleavage and Sub-Cellular Redistribution of Nuclear Pore Protein 98 by Coxsackievirus B3 Protease 2A Impairs Cardioprotection.
Hanson PJ; Hossain AR; Qiu Y; Zhang HM; Zhao G; Li C; Lin V; Sulaimon S; Vlok M; Fung G; Chen VH; Jan E; McManus BM; Granville DJ; Yang D
Front Cell Infect Microbiol; 2019; 9():265. PubMed ID: 31396490
[TBL] [Abstract][Full Text] [Related]
46. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
[TBL] [Abstract][Full Text] [Related]
47. The protective role of microRNA-21 against coxsackievirus B3 infection through targeting the MAP2K3/P38 MAPK signaling pathway.
He F; Xiao Z; Yao H; Li S; Feng M; Wang W; Liu Z; Liu Z; Wu J
J Transl Med; 2019 Oct; 17(1):335. PubMed ID: 31585536
[TBL] [Abstract][Full Text] [Related]
48. Obesity Exacerbates Coxsackievirus Infection via Lipid-Induced Mitochondrial Reactive Oxygen Species Generation.
Kim SR; Song JH; Ahn JH; Jeong MS; Yang YM; Cho J; Jeong JH; Cha Y; Kim KN; Kim HP; Chang SY; Ko HJ
Immune Netw; 2022 Apr; 22(2):e19. PubMed ID: 35573153
[TBL] [Abstract][Full Text] [Related]
49. Colchicine aggravates coxsackievirus B3 infection in mice.
Smilde BJ; Woudstra L; Fong Hing G; Wouters D; Zeerleder S; Murk JL; van Ham M; Heymans S; Juffermans LJ; van Rossum AC; Niessen HW; Krijnen PA; Emmens RW
Int J Cardiol; 2016 Aug; 216():58-65. PubMed ID: 27140338
[TBL] [Abstract][Full Text] [Related]
50. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
[TBL] [Abstract][Full Text] [Related]
51.
Lee YG; Park JH; Jeon ES; Kim JH; Lim BK
J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433
[TBL] [Abstract][Full Text] [Related]
52. Pyrrolidine dithiocarbamate reduces coxsackievirus B3 replication through inhibition of the ubiquitin-proteasome pathway.
Si X; McManus BM; Zhang J; Yuan J; Cheung C; Esfandiarei M; Suarez A; Morgan A; Luo H
J Virol; 2005 Jul; 79(13):8014-23. PubMed ID: 15956547
[TBL] [Abstract][Full Text] [Related]
53. Ubiquitination is required for effective replication of coxsackievirus B3.
Si X; Gao G; Wong J; Wang Y; Zhang J; Luo H
PLoS One; 2008 Jul; 3(7):e2585. PubMed ID: 18612413
[TBL] [Abstract][Full Text] [Related]
54. Miltefosine reduces coxsackievirus B3 lethality of mice with enhanced STAT3 activation.
Zhang CY; Hung CH; Hsiao YL; Chang TM; Su YC; Wang LC; Wang SM; Chen SH
Antiviral Res; 2024 Mar; 223():105824. PubMed ID: 38309307
[TBL] [Abstract][Full Text] [Related]
55. Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis.
Gauntt CJ; Paque RE; Trousdale MD; Gudvangen RJ; Barr DT; Lipotich GJ; Nealon TJ; Duffey PS
Infect Immun; 1983 Feb; 39(2):851-64. PubMed ID: 6299950
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of coxsackievirus B3 in cell cultures and in mice by peptide-conjugated morpholino oligomers targeting the internal ribosome entry site.
Yuan J; Stein DA; Lim T; Qiu D; Coughlin S; Liu Z; Wang Y; Blouch R; Moulton HM; Iversen PL; Yang D
J Virol; 2006 Dec; 80(23):11510-9. PubMed ID: 16987987
[TBL] [Abstract][Full Text] [Related]
57. Mucosal co-immunization with AIM2 enhances protective SIgA response and increases prophylactic efficacy of chitosan-DNA vaccine against coxsackievirus B3-induced myocarditis.
Chai D; Yue Y; Xu W; Dong C; Xiong S
Hum Vaccin Immunother; 2014; 10(5):1284-94. PubMed ID: 24614684
[TBL] [Abstract][Full Text] [Related]
58. Poly(rC) binding protein 1 benefits coxsackievirus B3 infection via suppressing the translation of p62/SQSTM1.
He HY; You Z; Ouyang T; Zhao G; Chen LJ; Wang Q; Li JY; Ye X; Zhang MH; Yang D; Ge XY; Qiu Y
Virus Res; 2022 Sep; 318():198851. PubMed ID: 35764193
[TBL] [Abstract][Full Text] [Related]
59. Acetylation of FOXO1 activates Bim expression involved in CVB3 induced cardiomyocyte apoptosis.
Hu Y; Yi L; Yang Y; Wu Z; Kong M; Kang Z; Yang Z
Apoptosis; 2023 Dec; ():. PubMed ID: 38127284
[TBL] [Abstract][Full Text] [Related]
60. Coxsackievirus B3 infection compromises endothelial-dependent vasodilation of coronary resistance arteries.
Choy JC; Lui AH; Moien-Afshari F; Wei K; Yanagawa B; McManus BM; Laher I
J Cardiovasc Pharmacol; 2004 Jan; 43(1):39-47. PubMed ID: 14668566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
